Thus, there may be a double dissociation as far as gamma oscillations and efficacy in MDD is concerned: an increase in acute gamma oscillations does not ensure a long-term efficacy against depression (lanicemine) while a lack of gamma oscillations does not preclude NR2B agents from being effective in the clinic against MDD (traxoprodil). Here, GRIN2B is linked to depressive symptom measurement.